These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6187720)

  • 1. Detection of non-HLA-DR determinants by alloreactive lymphocyte clones.
    Zeevi A; Annen K; Scheffel C; Duquesnoy RJ
    Hum Immunol; 1983 Feb; 6(2):97-109. PubMed ID: 6187720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of PLT specificity of alloreactive lymphocyte clones with HLA-DR, MB and MT determinants.
    Zeevi A; Scheffel C; Annen K; Bass G; Marrari M; Duquesnoy RJ
    Immunogenetics; 1982; 16(3):209-18. PubMed ID: 6183198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of HLA-DR associated PLT determinants by alloreactive lymphocyte clones.
    Zeevi A; Annen K; Scheffel C; Duquesnoy RJ
    Immunogenetics; 1983; 18(3):205-20. PubMed ID: 6604694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and functional evidence that an MT3 supertypic determinant defined by a monoclonal antibody is carried on the DR molecule on HLA-DR7 cell lines.
    Horibe K; Flomenberg N; Pollack MS; Adams TE; Dupont B; Knowles RW
    J Immunol; 1984 Dec; 133(6):3195-202. PubMed ID: 6208273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cells specific for different antigens express different HLA-D region products.
    Schendel DJ; Johnson JP
    Eur J Immunol; 1985 Dec; 15(12):1239-43. PubMed ID: 3878791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DR-, MB- and novel DC-related determinants restrict purified protein derivative of tuberculin (PPD)-stimulated human T cell proliferation.
    Pawelec G; Schneider EM; Müller C; Wernet P
    Eur J Immunol; 1985 Jan; 15(1):12-7. PubMed ID: 2578396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strong lymphoproliferative suppressive function of PLT clones specific for SB-like antigens.
    Pawelec G; Wernet P; Rosenlund R; Blaurock M; Schneider EM
    Hum Immunol; 1984 Mar; 9(3):145-57. PubMed ID: 6199336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primed lymphocyte testing specificity of alloreactive lymphocyte clones for HLA-B locus determinants.
    Zeevi A; Scheffel C; Annen K; Duquesnoy RJ
    Proc Natl Acad Sci U S A; 1983 Mar; 80(5):1440-4. PubMed ID: 6187013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of MHC class II and Tac antigens on IL2-activated human T cell clones that can stimulate in MLR, AMLR, PLT and can present antigen.
    Triebel F; de Roquefeuil S; Blanc C; Charron DJ; Debre P
    Hum Immunol; 1986 Mar; 15(3):302-15. PubMed ID: 2420767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of alloactivated human T lymphocyte clones in secondary proliferation, cell-mediated lympholysis and interleukin-2 release.
    Zeevi A; Duquesnoy RJ
    J Immunogenet; 1985 Feb; 12(1):17-31. PubMed ID: 2931486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human allospecific T cell proliferative clones: different T cell clones expressing an apparently identical HLA class II specificity are heterogeneous in regard to their proliferative inhibition by a panel of monoclonal antibodies against human Ia-like antigens.
    Bourgue F; Rebai N; Mawas C
    Hum Immunol; 1983 Sep; 8(1):33-40. PubMed ID: 6195133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential inhibition of human antigen-specific T cell clone proliferative responses by distinct monoclonal anti-HLA-DR antibodies.
    Triebel F; Missenard-Leblond V; Couty MC; Charron DJ; Debre P
    J Immunol; 1984 Apr; 132(4):1773-8. PubMed ID: 6199412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T cell clones allospecific for HLA-DR5 antigen with the OKT8 phenotype.
    Chardonnens X; Froment Y; Morgan G; Jeannet M
    Tissue Antigens; 1983 Jul; 22(1):76-81. PubMed ID: 6193608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen-specific T cell clones restricted by DR, DRw53 (MT), or DP (SB) Class II HLA molecules. Inhibition studies with monoclonal HLA-specific antibodies.
    Qvigstad E; Gaudernack G; Thorsby E
    Hum Immunol; 1984 Dec; 11(4):207-17. PubMed ID: 6210280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MT3 specificity resides on a novel human class II antigen distinct from the HLA-DR antigen and DC-like antigen.
    Yabe T; Suzuki M; Satake M; Juji T; Hamaguchi H
    Immunogenetics; 1984; 20(2):155-67. PubMed ID: 6205988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of human T-lymphocyte clones (TLCs) specific for HLA-region gene products.
    Eckels DD; Hartzman RJ
    Immunogenetics; 1982; 16(2):117-33. PubMed ID: 6183195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloreactive bovine T lymphocyte clones: an analysis of function, phenotype, and specificity.
    Teale AJ; Baldwin CL; Ellis JA; Newson J; Goddeeris BM; Morrison WI
    J Immunol; 1986 Jun; 136(12):4392-8. PubMed ID: 2423592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal mouse anti-I-Ak and anti-I-Ek antibodies cross-reacting with HLA-DR supertypic and subtypic determinants rather than classical DR allelic specificities.
    Pierres M; Mercier P; Madsen M; Mawas C; Kristensen T
    Tissue Antigens; 1982 Apr; 19(4):289-300. PubMed ID: 6179258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restriction molecules involved in the interaction of human T cell clones with antigen-presenting cells.
    Koide Y; Yoshida TO
    Immunol Lett; 1984; 7(4):209-13. PubMed ID: 6200432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenetic analysis of the HLA complex with alloreactive T cell clones.
    Duquesnoy RJ; Zeevi A
    Hum Immunol; 1983 Sep; 8(1):17-23. PubMed ID: 6226628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.